[Not Available].
作者信息
Belzile Mei-Ni, Bunce Paul E
机构信息
Division des maladies infectieuses (Belzile, Bunce), département de médecine, University of Toronto; division des maladies infectieuses (Bunce), University Health Network and Sinai Health System; département de médecine (Bunce), University of Toronto, Toronto, Ont.
出版信息
CMAJ. 2025 Jun 8;197(22):E633-E634. doi: 10.1503/cmaj.241220-f.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]。
CMAJ. 2025 Jun 8;197(22):E633-E634. doi: 10.1503/cmaj.241220-f.
本文引用的文献
1
Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database.与利奈唑胺给药相关的药物不良事件：一项使用FAERS数据库的2004年至2023年真实世界药物警戒研究。
Front Pharmacol. 2024 Feb 16;15:1338902. doi: 10.3389/fphar.2024.1338902. eCollection 2024.
2
Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2017-2021.2017 - 2021年加拿大急症护理医院中的医疗保健相关感染与抗菌药物耐药性
Can Commun Dis Rep. 2023 May 1;49(5):235-252. doi: 10.14745/ccdr.v49i05a09.
3
Antibiotic Myths for the Infectious Diseases Clinician.抗生素在感染性疾病临床中的误区
Clin Infect Dis. 2023 Oct 13;77(8):1120-1125. doi: 10.1093/cid/ciad357.
4
Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia.利奈唑胺与达托霉素治疗万古霉素耐药肠球菌菌血症的系统评价和荟萃分析。
Antimicrob Agents Chemother. 2014;58(2):734-9. doi: 10.1128/AAC.01289-13. Epub 2013 Nov 18.
5
Linezolid: the first oxazolidinone antimicrobial.利奈唑胺：首个恶唑烷酮类抗菌药物。
Ann Intern Med. 2003 Jan 21;138(2):135-42. doi: 10.7326/0003-4819-138-2-200301210-00015.
Zotero 插件